Physician profile
Sun Young Lee
NPI 1649613647
$96,574.19
in general payments reported to CMS, 2019-2025
12 companies · $5,445 in 2025
The $5,445 reported for 2025 was more than what 94% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $257 · 2020: $142 · 2021: $23.82 · 2022: $928 · 2023: $83K · 2024: $6,666 · 2025: $5,445.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $83K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $10K · Travel and Lodging: $1,244 · Food and Beverage: $980.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $83,000.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $10,000.00 |
| Travel and Lodging | $1,243.80 |
| Food and Beverage | $979.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Research LLC | $93,431.95 | 2023-2025 | |
| Alcon Vision LLC | $1,662.94 | 2022-2025 | Hydrus Microstent, Constellation |
| Pfizer INC. | $360.93 | 2019-2024 | |
| Alimera Sciences, INC. | $306.79 | 2022-2024 | Iluvien, Yutiq |
| Johnson & Johnson Surgical Vision, INC. | $275.58 | 2022-2025 | Tecnis Simplicity |
| Novartis Pharmaceuticals Corporation | $239.70 | 2020-2022 | |
| Abbvie INC. | $112.24 | 2023 | |
| Eyepoint US, INC. | $108.42 | 2022 | |
| Genentech USA, INC. | $23.82 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $17.76 | 2019 | |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 | |
| Apellis Pharmaceuticals, INC. | $16.82 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sun Young Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.